13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 15 holding rows worth $770,122,933.
- Accession
- 0001826434-26-000002
- Filer
- CIK 1826434
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 15 entries on the cover page, a total value of $770,122,933 stated on the cover page (in dollars after the unit check, H1), rows summing to $770,122,933 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 478160104 | COM | 603,143 | $124,820,444 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 346,875 | $79,406,625 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 63,284 | $68,010,049 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 120,921 | $58,918,757 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 265,015 | $56,511,799 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 86,023 | $50,094,634 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 520,508 | $49,630,438 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,435,865 | $44,813,347 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 557,174 | $44,078,035 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 805,689 | $40,800,091 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 201,627 | $36,825,155 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 37,653 | $31,664,290 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 307,371 | $30,918,449 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 421,600 | $27,981,592 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 622,403 | $25,649,228 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-26-000002 | this filing | 2026-02-17 | acceptance time not in the bulk data set |